Nutt CL - Search Results

1

Histology-based expression profiling yields novel prognostic markers in human glioblastoma.

Dong S, Nutt CL, Betensky RA, Stemmer-Rachamimov AO, Denko NC, Ligon KL, Rowitch DH, Louis DN. Dong S, et al. Among authors: nutt cl. J Neuropathol Exp Neurol. 2005 Nov;64(11):948-55. doi: 10.1097/01.jnen.0000186940.14779.90. J Neuropathol Exp Neurol. 2005. PMID: 16254489 Free PMC article.

2

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Nutt CL, et al. Cancer Res. 2003 Apr 1;63(7):1602-7. Cancer Res. 2003. PMID: 12670911

3

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.

Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH. Ligon KL, et al. Among authors: nutt cl. J Neuropathol Exp Neurol. 2004 May;63(5):499-509. doi: 10.1093/jnen/63.5.499. J Neuropathol Exp Neurol. 2004. PMID: 15198128

4

Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers.

Betensky RA, Nutt CL, Batchelor TT, Louis DN. Betensky RA, et al. Among authors: nutt cl. J Mol Diagn. 2005 May;7(2):276-82. doi: 10.1016/S1525-1578(10)60555-7. J Mol Diagn. 2005. PMID: 15858152 Free PMC article.

5

Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.

Rousseau A, Nutt CL, Betensky RA, Iafrate AJ, Han M, Ligon KL, Rowitch DH, Louis DN. Rousseau A, et al. Among authors: nutt cl. J Neuropathol Exp Neurol. 2006 Dec;65(12):1149-56. doi: 10.1097/01.jnen.0000248543.90304.2b. J Neuropathol Exp Neurol. 2006. PMID: 17146289

6

Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.

Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN, Nutt CL. Mizoguchi M, et al. Among authors: nutt cl. J Neuropathol Exp Neurol. 2006 Dec;65(12):1181-8. doi: 10.1097/01.jnen.0000248549.14962.b2. J Neuropathol Exp Neurol. 2006. PMID: 17146292

7

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma.

Mueller W, Nutt CL, Ehrich M, Riemenschneider MJ, von Deimling A, van den Boom D, Louis DN. Mueller W, et al. Among authors: nutt cl. Oncogene. 2007 Jan 25;26(4):583-93. doi: 10.1038/sj.onc.1209805. Epub 2006 Aug 14. Oncogene. 2007. PMID: 16909125

8

Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.

Mizoguchi M, Nutt CL, Mohapatra G, Louis DN. Mizoguchi M, et al. Among authors: nutt cl. Brain Pathol. 2004 Oct;14(4):372-7. doi: 10.1111/j.1750-3639.2004.tb00080.x. Brain Pathol. 2004. PMID: 15605984 Free PMC article.

9

YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.

Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO. Nutt CL, et al. Clin Cancer Res. 2005 Mar 15;11(6):2258-64. doi: 10.1158/1078-0432.CCR-04-1601. Clin Cancer Res. 2005. PMID: 15788675

10

Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.

de la Iglesia N, Konopka G, Lim KL, Nutt CL, Bromberg JF, Frank DA, Mischel PS, Louis DN, Bonni A. de la Iglesia N, et al. Among authors: nutt cl. J Neurosci. 2008 Jun 4;28(23):5870-8. doi: 10.1523/JNEUROSCI.5385-07.2008. J Neurosci. 2008. PMID: 18524891 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters